VarmX develops a modified factor Xa as a reversal agent for anti-coagulants.
Total raised: $77.021989M
Investors 4
| Date | Name | Website |
| - | UNIIQ | uniiq.nl |
| - | BioGenerat... | biogenerat... |
| - | Ysios Capi... | ysioscapit... |
| - | Life Scien... | lspvc.com |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 25.05.2023 | - | $32.168684... | - | finsmes.co... |
| 09.07.2020 | Series B | $36.12207M | - | webcapital... |
| 02.07.2018 | Series A | $8.731235M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 25.05.2023 | VarmX Raises €30M in Series B2 Financing | VarmX, a Leiden, Netherlands-based biotech company focusing on the development of approaches for the... | finsmes.co... |
| 25.05.2023 | VarmX raises €30M to develop therapeutic proteins that resto... | Leiden-based VarmX, a biotech company developing “innovative” approaches for the reversal of anticoa... | siliconcan... |
| 18.10.2021 | EU Commission selects 65 startups to receive €363M funding t... | The European Commission has announced that it has selected 65 innovative startups and SMEs to be fun... | siliconcan... |
| 09.07.2020 | VarmX raises €32M in Series B financing to develop innovativ... | 08/07/2020 Press release VARMX RAISES €32 MILLION IN SERIES B FINANCING TO DEVELOP INNOVATIVE REVE... | webcapital... |
| 02.07.2018 | VarmX Closes € 7.5M Series A Financing Round | VarmX, a Leiden, The Netherlands-based biotech company focusing on the development of therapies in t... | finsmes.co... |
| 27.06.2017 | VarmX Closes Seed Financing Round | VarmX, a Leiden, Netherlands-based biotech company focusing on the development of therapies in the f... | finsmes.co... |
| - | VarmX | “Home | Varmx” | fastfounde... |